| Artículo | 2025 |
Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis
|
JHEP Reports |
| Artículo | 2024 |
Ammonia-induced stress response in liver disease progression and hepatic encephalopathy.
|
Nature Reviews Gastroenterology and Hepatology |
| Artículo | 2024 |
Biomarcadores en MASLD, ¿estamos ante una nueva era?
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Revisión | 2024 |
Circular RNAs in non-alcoholic fatty liver disease: Functions and clinical significance
|
RNA BIOLOGY |
| Artículo | 2024 |
Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease
|
EUROPEAN JOURNAL OF INTERNAL MEDICINE |
| Artículo | 2024 |
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| Artículo | 2024 |
FIB-4 score as predictor of COVID-19-related severity in hospitalized patients.
|
Revista Española de Enfermedades Digestivas |
| Artículo | 2024 |
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression
|
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL |
| Letter | 2024 |
Letter to the Editor: Serum Identification of At-Risk MASH: The Metabolomics-Advanced Steatohepatitis Fibrosis Score (MASEF)
|
HEPATOLOGY |
| Artículo | 2024 |
Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| Artículo | 2024 |
Low penetrance of frequent ATP7B mutations explains the low prevalence of Wilson disease. Lessons from real-life registries.
|
DIGESTIVE AND LIVER DISEASE |
| Revisión | 2024 |
Novel insights into metabolic-associated steatotic liver disease preclinical models
|
LIVER INTERNATIONAL |
| Artículo | 2024 |
One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population
|
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL |
| Artículo | 2024 |
Predictive factors for decompensating events in cirrhotic patients with primary biliary cholangitis under different lines of therapy
|
HEPATOLOGY |
| Short Survey | 2024 |
Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Artículo | 2024 |
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: results from the ColHai registry
|
LIVER INTERNATIONAL |
| Artículo | 2024 |
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
|
GUT |
| Artículo | 2024 |
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
|
HEPATOLOGY |
| Artículo | 2024 |
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
|
Journal of Gastroenterology |
| Artículo | 2024 |
Three double-dose reinforced hepatitis B revaccination scheme for patients with cirrhosis unresponsive to the standard regimen: an open-label randomised clinical trial
|
GUT |
| Letter | 2023 |
A second update on mapping the human genetic architecture of COVID-19.
|
NATURE |
| Artículo | 2023 |
AEEH «Consensus about detection and referral of hidden prevalent liver diseases»
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Artículo | 2023 |
An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography.
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2023 |
Analysis of the diagnostic accuracy of the non-invasive fibrosis indices NFS, HFS, and FIB-4 in the staging of advanced fibrosis in patients with metabolic fatty liver: meta-analysis of comparative studies
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2023 |
At- risk nash identification using an algorithm that combines fib-4+masef ( metabolomicsadvanced steatohepatitis fibrosis score)
|
HEPATOLOGY |
| Resumen congreso | 2023 |
Biomarkers of endothelial dysfunction in patients with nonalcoholic fatty liver disease (NAFLD)
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2023 |
Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis.
|
Biomarker Research |
| Revisión | 2023 |
Clinical application of Magnetic resonance elastography in hepatocellular carcinoma: From diagnosis to prognosis
|
ANNALS OF HEPATOLOGY |
| Corrección | 2023 |
Corrigendum to “Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis” (Journal of Hepatology (2023) 79(4) (967–976), (S0168827823003513), (10.1016/j.jhep.2023.05.022))
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2023 |
Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2023 |
Development and validation of the AMMON-OHE model to risk stratify cirrhotic outpatients for ocurrence of overt hepatic encephalopathy
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2023 |
EFFECTIVENESS AND SAFETY OF SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS (PBC): A PROSPECTIVE MULTICENTER REAL-WORLD COHORT
|
HEPATOLOGY |
| Resumen congreso | 2023 |
Endothelial and platelet-derived microvesicles as a biomarker of cardiovascular risk in patients with metabolic dysfunction-associated fatty liver disease (MAFLD)
|
JOURNAL OF HEPATOLOGY |
| Revisión | 2023 |
Enfermedad de Wilson
|
MEDICINA CLINICA |
| Resumen congreso | 2023 |
First nationwide genetic study on Wilson disease (Spanish Wilson registry): high diversity in mutations and in use of genetic evaluation, association with clinical data and influence on diagnosis and health costs
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2023 |
Glutaminolysis and Steatosis to Steatohepatitis Transition: Role of Glutaminase
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
| Resumen congreso | 2023 |
HISTOLOGICAL CLASSIFICATIONS AND PREDICTION OF LIVER- RELATED EVENTS : RESULTS FROM THE MULTICENTRIC, EUROPEAN, HEPATIC OUTCOMES AND SURVIVAL FATTY LIVER REGISTRY ( HOTSURFR) STUDY
|
HEPATOLOGY |
| Resumen congreso | 2023 |
Histological classifications versus liver-related events: results from the multicentric, European, hepatic outcomes and survival fatty liver registry (HOTSURFR) study
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2023 |
Identification of new serological biomarkers for the detection of significant fibrosis
|
HEPATOLOGY |
| Resumen congreso | 2023 |
Impact of obesity on transient elastography accuracy among patients with non-alcoholic fatty liver disease
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2023 |
Impact of the metabolic profile on the response to ursodeoxycholic acid in patients with primary biliary cholangitis: results of the ColHai registry
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2023 |
Impacto de la enseñanza integrada de la patología médico-quirúrgica en pequeños grupos basada en la resolución de problemas en el aprendizaje de la medicina
|
Innova medica: revista de innovación docente de la Facultad de Medicina de Sevilla |
| Artículo | 2023 |
Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals
|
INFLAMMATORY BOWEL DISEASES |
| Resumen congreso | 2023 |
Lessons from population genomics for Wilson disease: Prevalence, penetrance of mutations, clinical implications and design of regional screening programmes
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2023 |
Liver cancer stem cell dissemination and metastasis: uncovering the role of NRCAM in hepatocellular carcinoma
|
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
| Artículo | 2023 |
Liver stiffness accuracy by MR elastography in histologically proven non-alcoholic fatty liver disease patients: a Spanish cohort
|
Revista Española de Enfermedades Digestivas |
| Resumen congreso | 2023 |
Long-term prospective follow-up of a primary biliary cholangitis (PBC) multicenter cohort treated with Obeticholic Acid (OCA). Interaction effect of triple therapy with fibrates
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2023 |
Main clinical characteristics and evolutionary events among patients suffering Wilson disease in Spain: first results from the Spanish Wilson registry
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2023 |
Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis
|
CELL DEATH & DISEASE |
| Resumen congreso | 2023 |
NOVEL ARTIFICIAL INTELLIGENCE-ASSISTED DIGITAL PATHOLOGY QUANTITATIVE IMAGE ANALYSIS PREDICTS THE OCCURRENCE OF LIVER-RELATED CLINICAL EVENTS IN THE MULTICENTRIC, EUROPEAN, HEPATIC OUTCOMES AND SURVIVAL FATTY LIVER REGISTRY (HOTSURFR) STUDY
|
HEPATOLOGY |
| Resumen congreso | 2023 |
Novel artificial intelligence-assisted digital pathology quantitative image analysis predicts the occurrence of liver-related clinical events in the multicentric, European, hepatic outcomes and survival fatty liver registry (HOTSURFR) study
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2023 |
Predicting liver-related events in NAFLD: A predictive model
|
HEPATOLOGY |
| Resumen congreso | 2023 |
PREDICTION OF BIOCHEMICAL RESPONSE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH OBETICHOLIC ACID: DERIVATION AND EXTERNAL VALIDATION OF THE OCA RESPONSE SCORE (ORS)
|
HEPATOLOGY |
| Editorial | 2023 |
Prognostication in Advanced Chronic Liver Disease Using Liver Stiffness Measurement: Repetita Iuvant
|
GASTROENTEROLOGY |
| Artículo | 2023 |
Reingresos hospitalarios en pacientes cirróticos: un desafío en el horizonte
|
Revista Andaluza de Patología Digestiva |
| Resumen congreso | 2023 |
Risk of decompensated cirrhosis in patients with primary biliary cholangitis under first, second and third-line therapies
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2023 |
Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebocontrolled trial
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2023 |
Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD.
|
LIVER INTERNATIONAL |
| Artículo | 2023 |
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant
|
HEPATOLOGY COMMUNICATIONS |
| Resumen congreso | 2023 |
Single-cell RNA sequencing in DIAMOND mice reveals differentially regulated pathways specifically associated with the transition from simple steatosis towards NASH
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2023 |
The combination of LACE index, MELDon discharge and a previous history of decompensation defines risk groups for early readmission in patients with liver cirrhosis
|
JOURNAL OF HEPATOLOGY |
| Revisión | 2023 |
The essential role of IL-17 as the pathogenetic link between psoriasis and metabolic-associated fatty liver disease
|
Life |
| Resumen congreso | 2023 |
Variation in the presentation pattern of primary biliary cholangitis (PBC) in Spain according to the diagnostic period: data from the Spanish registry of cholestatic and autoimmune liver diseases (COLHAI)
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2022 |
A 2-step strategy combining FIB-4 with transient elastography and ultrasound predicted liver cancer after HCV cure
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
| Artículo | 2022 |
A shortcut from metabolic-associated fatty liver disease (MAFLD) to hepatocellular carcinoma (HCC): c-MYC a promising target for preventative strategies and individualized therapy
|
CANCERS |
| Resumen congreso | 2022 |
Approaches for a hepatitis C-free city: preliminary results
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2022 |
Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool
|
Biomarker Research |
| Artículo | 2022 |
Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease
|
FRONTIERS IN MEDICINE |
| Artículo | 2022 |
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
|
GUT |
| Artículo | 2022 |
Co-12. Eficacia y seguridad de las prótesis de aposición luminal en el drenaje ecoendoscópico de colecciones abdominales y la influencia del catéter pigtail coaxial en la tasa de complicaciones y de revisiones endoscópicas.
|
Revista Andaluza de Patología Digestiva |
| Resumen congreso | 2022 |
Confounding factors in diagnostic performance of magnetic resonance elastography for staging liver fibrosis in patients with non-alcoholic fatty liver disease: an individual patient data meta-analysis
|
JOURNAL OF HEPATOLOGY |
| Revisión | 2022 |
Contribution of liver and pancreatic islet crosstalk to β-cell function/dysfunction in the presence of fatty liver
|
Frontiers in Endocrinology |
| Corrección | 2022 |
Correction to: A 2-step strategy combining FIB-4 with transient elastography and ultrasound predicted liver cancer after HCV cure
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
| Artículo | 2022 |
Derivation and validation of the NAFLD Cirrhosis Score (NCS) to distinguish bridging fibrosis from cirrhosis
|
EUROPEAN JOURNAL OF INTERNAL MEDICINE |
| Resumen congreso | 2022 |
Diagnostic accuracy of MRE for staging hepatic fibrosis in patients with NAFLD
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2022 |
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis
|
GUT |
| Resumen congreso | 2022 |
Dysregulation of the urea cycle enzymes determines a more severe NAFLD phenotype in a DIAMOND preclinical model
|
JOURNAL OF HEPATOLOGY |
| Revisión | 2022 |
Emerging pharmacological treatment options for MAFLD
|
Therapeutic Advances in Endocrinology and Metabolism |
| Resumen congreso | 2022 |
EpCAM+CD133+Microvesicles: novel biomarker in NAFLD
|
HEPATOLOGY |
| Artículo | 2022 |
Extracellular Vesicles as Biomarkers in Liver Disease
|
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| Revisión | 2022 |
General overview about the current management of nonalcoholic fatty liver disease
|
CLINICAL DRUG INVESTIGATION |
| Resumen congreso | 2022 |
Glutaminolysis and steatosis to steatohepatitis transition: role of glutaminase
|
HEPATOLOGY |
| Artículo | 2022 |
Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies.
|
Journal of Clinical and Translational Hepatology |
| Resumen congreso | 2022 |
Identification of new potential biomarkers to follow steatohepatitis in patients with non-alcoholic/metabolic-associated fatty liver disease
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2022 |
Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients
|
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| Resumen congreso | 2022 |
Impact of genes related to metabolic associated fatty liver disease (MAFLD) in response to hypocaloric dietary intervention: nutrigenomic analysis
|
HEPATOLOGY |
| Artículo | 2022 |
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2022 |
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
|
Scientific reports |
| Artículo | 2022 |
Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis.
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| Artículo | 2022 |
Long non-coding RNA H19 as a biomarker for hepatocellular carcinoma
|
LIVER INTERNATIONAL |
| Revisión | 2022 |
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Artículo | 2022 |
Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2022 |
Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2022 |
Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology
|
LIVER INTERNATIONAL |
| Artículo | 2022 |
Prevalence of non-alcoholic fatty liver disease (NAFLD) in a cohort of patients with type 2 diabetes: the PHIGNA-DM2 study
|
NUTRICION HOSPITALARIA |
| Letter | 2022 |
Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes
|
GUT |
| Resumen congreso | 2022 |
Safety and effectiveness of vaccines agains SARS-COV-2 in patients with liver cancer. VacHep registry: response analysis 4 weeks after the second dose.
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2022 |
Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD
|
Journal of Gastroenterology |
| Artículo | 2021 |
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality.
|
JOURNAL OF CLINICAL INVESTIGATION |
| Artículo | 2021 |
An experimental DUAL model of advanced liver damage
|
HEPATOLOGY COMMUNICATIONS |
| Revisión | 2021 |
Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
|
FRONTIERS IN IMMUNOLOGY |
| Resumen congreso | 2021 |
Circulating PCSK9 levels are correlated with advanced disease in patients with biopsy-proven non-alcoholic fatty liver disease.
|
ATHEROSCLEROSIS |
| Artículo | 2021 |
Clinical characteristics and outcome of drug-induced liver injury in the older patients: from the young-old to the oldest-old
|
CLINICAL PHARMACOLOGY & THERAPEUTICS |
| Artículo | 2021 |
CO-03. Impacto del tratamiento antiviral con tenofovir para la hepatitis crónica b en la incidencia de infección sars-cov-2 y covid-19. Estudio multicéntrico covhb
|
Revista Andaluza de Patología Digestiva |
| Artículo | 2021 |
CO-14. Evaluación de la capacidad diagnóstica de fibrosis y cuantificación de esteatosis hepática mediante rm en pacientes con esteatosis hepática metabólica (ehmet)
|
Revista Andaluza de Patología Digestiva |
| Artículo | 2021 |
CO-16. Colangitis biliar primaria e infección por sars-cov-2: Incidencia, susceptibilidad y resultados
|
Revista Andaluza de Patología Digestiva |
| Artículo | 2021 |
Combination of squamous cell carcinoma antigen immunocomplex and alpha-fetoprotein in mid- And long-term prediction of hepatocellular carcinoma among cirrhotic patients
|
WORLD JOURNAL OF GASTROENTEROLOGY |
| Artículo | 2021 |
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry
|
JOURNAL OF HEPATOLOGY |
| Letter | 2021 |
COVID-19 and the liver: the chicken or the egg dilemma
|
Revista Española de Enfermedades Digestivas |
| Artículo | 2021 |
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: a longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects
|
LIVER INTERNATIONAL |
| Artículo | 2021 |
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection
|
CELLULAR & MOLECULAR IMMUNOLOGY |
| Artículo | 2021 |
Development and validation of a clinical-genetic risk score to predict hepatic encephalopathy in patients with liver cirrhosis.
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
| Artículo | 2021 |
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2021 |
Effectiveness and safety of obeticholic acid in a Southern European multicenter cohort of patients with primary biliary cholangitis and suboptimal response to ursodeoxycholic acid
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| Resumen congreso | 2021 |
Impact of a loss-of-function variant in HSD17B13 on hepatic decompensation and mortality in cirrhotic patients
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2021 |
Impact of COVID-19 on liver disease: From the experimental to the clinic perspective.
|
World journal of virology |
| Artículo | 2021 |
Impact of liver injury on the severity of COVID-19: a systematic review with meta-analysis
|
Revista Española de Enfermedades Digestivas |
| Artículo | 2021 |
Interrelación entre esteatosis hepática metabólica y diabetes mellitus e hipertensión arterial
|
REVISTA DE NUTRICION PRACTICA |
| Artículo | 2021 |
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease.
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2021 |
Management of NAFLD patients with advanced fibrosis
|
LIVER INTERNATIONAL |
| Artículo | 2021 |
Mapping the human genetic architecture of COVID-19.
|
NATURE |
| Artículo | 2021 |
Monitoring occurrence of liver-related events and survival by transient elastography in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| Artículo | 2021 |
Precisión diagnóstica y limitaciones de los test no invasivos en pacientes con esteatosis hepática metabólica
|
Revista Andaluza de Patología Digestiva |
| Editorial | 2021 |
Propuesta de nueva denominación: esteatosis hepática metabólica (EHmet)
|
Revista Española de Enfermedades Digestivas |
| Letter | 2021 |
Reply to: “The predictive value of significant fibrosis for metabolic disturbances in patients with NAFLD”
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2021 |
SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome
|
Scientific reports |
| Artículo | 2021 |
Simple non-invasive scoring systems and histologic scores in predicting mortality in NAFLD patients: a systematic review and meta-analysis
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| Letter | 2021 |
Sofosbuvir improves HCV-induced insulin resistance by blocking IRS1 degradation
|
Clinical and translational medicine |
| Revisión | 2021 |
Wilson's disease: revisiting an old friend
|
World Journal of Hepatology |
| Artículo | 2020 |
Bacterial antigen translocation and age as BMI-independent contributing factors on systemic inflammation in NAFLD patients
|
LIVER INTERNATIONAL |
| Artículo | 2020 |
Co-12. Análisis de factores que afectan la seguridad diagnóstica de la elastografía por resonancia magnética (erm) en pacientes con mafld.
|
Revista Andaluza de Patología Digestiva |
| Artículo | 2020 |
Co-17. Determinación de micropartículas apoptóticas de origen hepático en pacientes con enfermedad hepática metabólica grasa
|
Revista Andaluza de Patología Digestiva |
| Revisión | 2020 |
COVID-19 and the digestive system: protection and management during the SARS-CoV-2 pandemic
|
Revista Española de Enfermedades Digestivas |
| Artículo | 2020 |
Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| Corrección | 2020 |
Erratum to: “Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2020 |
Hepatitis C virus clearance by direct-acting antivirals agents improves endothelial dysfunction and subclinical atherosclerosis: HEPCAR study
|
Clinical and translational gastroenterology |
| Artículo | 2020 |
Manejo de la enfermedad hepática metabólica grasa
|
Revista Andaluza de Patología Digestiva |
| Capítulo | 2020 |
Morbid obesity and hepatitis C: treat as normal or are there additional issues to consider?
|
Clinical Dilemmas in Viral Liver Disease, Second Edition |
| Artículo | 2020 |
Nonalcoholic fatty liver disease and the risk of metabolic comorbidities: how to manage in clinical practice
|
Polish archives of internal medicine |
| Artículo | 2020 |
Oral glutamine challenge is a marker of altered ammonia metabolism and predicts the risk of hepatic encephalopathy
|
LIVER INTERNATIONAL |
| Editorial | 2020 |
Reflex testing. A key tool for the elimination of hepatitis C
|
Revista Española de Enfermedades Digestivas |
| Artículo | 2020 |
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2020 |
Stratification of patients in NASH clinical trials: a pitfall for trial success
|
JHEP Reports |
| Capítulo | 2020 |
The spectrum of NAFLD: From the organ to the system
|
NAFLD and NASH: biomarkers in detection, diagnosis and monitoring |
| Artículo | 2019 |
Analysis of the burden and variability in the management of NAFLD patients in the clinical practice: unifying the required criteria
|
Revista Española de Enfermedades Digestivas |
| Artículo | 2019 |
Co-27. Índice de fibrosis hepática: Estratificación del riesgo de enfermedad hepática metabólica grasa en atención primaria.
|
Revista Andaluza de Patología Digestiva |
| Resumen congreso | 2019 |
Droplet digital pcr analysis of circulating lncrna h19: a potential biomarker for hepatocellular carcinoma
|
HEPATOLOGY |
| Artículo | 2019 |
Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD)
|
Revista Española de Enfermedades Digestivas |
| Artículo | 2019 |
Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models
|
Revista Española de Enfermedades Digestivas |
| Artículo | 2019 |
Quality of life in patients with hepatitis C. Importance of treatment
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Resumen congreso | 2019 |
Sesión IV.: Búsqueda de biomarcadores en la enfermedad hepática metabólica grasa: aproximación transcriptómica
|
Revista Andaluza de Patología Digestiva |
| Artículo | 2019 |
Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2019 |
Usefulness of bioelectrical impedance analysis for monitoring patients with refractory ascites
|
Revista Española de Enfermedades Digestivas |
| Artículo | 2018 |
Co-12. Determinantes genéticos de encefalopatía hepática en pacientes con cirrosis: Análisis de genes candidatos
|
Revista Andaluza de Patología Digestiva |
| Resumen congreso | 2018 |
Co-13. Disminución de micropartículas apoptóticas endoteliales y plaquetarias en pacientes con hepatitis c tras el tratamiento con aad
|
Revista Andaluza de Patología Digestiva |
| Resumen congreso | 2018 |
Co-20. Mejora de la función endotelial en pacientes con virus c tras el tratamiento con aad
|
Revista Andaluza de Patología Digestiva |
| Resumen congreso | 2018 |
Co-21. Uso de microarns como biomarcadores no invasivos en enfermedad hepática metabólica por depósito de grasa no alcohólica
|
Revista Andaluza de Patología Digestiva |
| Artículo | 2018 |
Co-28. Carga y variabilidad en el manejo de pacientes con ehgna en la práctica clínica: Hacia criterios unificados
|
Revista Andaluza de Patología Digestiva |
| Resumen congreso | 2018 |
Co-29. Investigación traslacional en ehgna: Estudio genético y funcional de fgf-21
|
Revista Andaluza de Patología Digestiva |
| Artículo | 2018 |
Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis
|
LIVER INTERNATIONAL |
| Artículo | 2018 |
Duration of the acute hepatic encephalopathy episode determines survival in cirrhotic patients
|
Therapeutic Advances in Gastroenterology |
| Editorial | 2018 |
Editorial: looking for patients at risk of cirrhosis in the general population-many needles in a haystack
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| Artículo | 2018 |
Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| Artículo | 2018 |
Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2018 |
Metformin modifies glutamine metabolism in an in vitro and in vivo model of hepatic encephalopathy
|
Revista Española de Enfermedades Digestivas |
| Artículo | 2018 |
Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| Revisión | 2018 |
miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
|
JOURNAL OF HEPATOLOGY |
| Revisión | 2018 |
Nuevas perspectivas terapéuticas en la esteatohepatitis no alcohólica
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Artículo | 2018 |
Peer-to-Peer Sessions in Primary Care to Improve the Hepatitis B Detection Rate in Seville, Spain
|
ANNALS OF HEPATOLOGY |
| Resumen congreso | 2018 |
Role of the Long Non-Coding RNA H19 in the Context of Hepatocellular Carcinoma
|
HEPATOLOGY |
| Artículo | 2018 |
Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy
|
PLOS ONE |
| Editorial | 2018 |
Solving doubts about L-ornithine L-aspartate for overt hepatic encephalopathy: Whom and how to treat
|
HEPATOLOGY |
| Artículo | 2018 |
The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| Revisión | 2018 |
The impact of minimal hepatic encephalopathy treatment in long-term prognosis
|
Salud(i)Ciencia |
| Editorial | 2017 |
Acute-on-chronic liver failure: a time to step forward
|
Revista Española de Enfermedades Digestivas |
| Revisión | 2017 |
Cardiovascular assessment in liver transplant for nonalcoholic steatohepatitis patients: What we do, what we should do
|
World Journal of Hepatology |
| Artículo | 2017 |
Co-11. La frecuencia crítica de parpadeo mejora su rendimiento diagnóstico y predictivo de encefalopatía hepática al incorporar la desviación estándar como criterio de calidad
|
Revista Andaluza de Patología Digestiva |
| Artículo | 2017 |
Co-12. Papel del factor de crecimiento de fibroblasto 21 (fgf21) en pacientes con eghna: Estudio genético y funcional
|
Revista Andaluza de Patología Digestiva |
| Artículo | 2017 |
Co-19. Estudio del perfil epigenético en una cohorte de pacientes con hepatitis crónica c: Cirróticos versus hepatocarcinoma
|
Revista Andaluza de Patología Digestiva |
| Artículo | 2017 |
Co-20. Validación de los índices fib 4 y nfs para discriminar fibrosis hepática en pacientes con eghna en práctica clínica habitual.
|
Revista Andaluza de Patología Digestiva |
| Artículo | 2017 |
Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort
|
JOURNAL OF VIRAL HEPATITIS |
| Artículo | 2017 |
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2017 |
Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy
|
LIVER INTERNATIONAL |
| Artículo | 2017 |
Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| Revisión | 2016 |
Case Report: Acute-on-Chronic Liver Failure: Making the Diagnosis between Infection and Acute Alcoholic Hepatitis
|
SEMINARS IN LIVER DISEASE |
| Artículo | 2016 |
FibroGENE: A gene-based model for staging liver fibrosis
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2016 |
Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment options
|
WORLD JOURNAL OF GASTROENTEROLOGY |
| Artículo | 2016 |
Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease
|
Scientific reports |
| Artículo | 2016 |
Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis
|
WORLD JOURNAL OF GASTROENTEROLOGY |
| Artículo | 2016 |
New technologies - new insights into the pathogenesis of hepatic encephalopathy
|
METABOLIC BRAIN DISEASE |
| Artículo | 2016 |
Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| Revisión | 2016 |
Pharmacogenetics of ribavirin-induced anemia in hepatitis C
|
PHARMACOGENOMICS |
| Artículo | 2016 |
Remission maintained by monotherapy after biological plus immunosuppressive combination for Crohn's disease in clinical practice
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| Revisión | 2016 |
Role of assessing liver fibrosis in management of chronic hepatitis C virus infection
|
CLINICAL MICROBIOLOGY AND INFECTION |
| Artículo | 2016 |
Sedación endoscópica en la cirrosis hepática
|
Revista Andaluza de Patología Digestiva |
| Ponencia | 2016 |
Validación preliminar de la aplicación Cliente/Servidor del software DeMILI para el diagnóstico de enfermedades del hígado
|
CASEIB 2016 XXXIV Congreso Anual de la Sociedad Española de Ingeniería Biomédica: Libro de actas |
| Artículo | 2015 |
2. Continuidad asistencial de la hepatitis c desde la deteccion al tratamiento: Impacto de las sesiones formativas en atencion primaria.
|
Revista Andaluza de Patología Digestiva |
| Artículo | 2015 |
28. Impacto de la medición objetiva de comorbilidades en el beneficio de la terapia antiviral libre de interferón en hepatitis C
|
Revista Andaluza de Patología Digestiva |
| Revisión | 2015 |
Assessing cardiovascular risk in hepatitis C: An unmet need
|
World Journal of Hepatology |
| Artículo | 2015 |
Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: Meta-analysis
|
Revista Española de Enfermedades Digestivas |
| Artículo | 2015 |
Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection
|
Genes & Immunity |
| Artículo | 2015 |
Hepatitis C Virus Current and Evolving Treatments for Genotypes 2 and 3
|
GASTROENTEROLOGY CLINICS OF NORTH AMERICA |
| Artículo | 2015 |
Minimal Hepatic Encephalopathy and Critical Flicker Frequency Are Associated With Survival of Patients With Cirrhosis
|
GASTROENTEROLOGY |
| Artículo | 2015 |
Prediction of Week 4 Virological Response in Hepatitis C for Making Decision on Triple Therapy: The Optim Study
|
PLOS ONE |
| Revisión | 2015 |
Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin
|
World Journal of Hepatology |
| Artículo | 2015 |
Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment
|
JOURNAL OF CLINICAL VIROLOGY |
| Capítulo | 2015 |
The oral glutamine challenge in liver cirrhosis
|
Glutamine in Clinical Nutrition |
| Letter | 2015 |
Trombosis portal: más allá de la cirrosis hepática
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Editorial | 2014 |
Deciphering the Spectrum of Low-Grade Hepatic Encephalopathy in Clinical Practice
|
GASTROENTEROLOGY |
| Revisión | 2014 |
HCV genotype 3 - the new treatment challenge
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| Artículo | 2014 |
Hepatotoxicidad inducida por estanozolol
|
Revista Andaluza de Patología Digestiva |
| Letter | 2014 |
Hypoxic hepatitis as diabetic ketoacidosis complication
|
Revista Española de Enfermedades Digestivas |
| Artículo | 2014 |
PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C
|
ANNALS OF HEPATOLOGY |
| Artículo | 2014 |
Polycystic liver in the adult (PLA) in Spain: Analysis of a structured survey analysing the experience and attitude of Spanish gastroenterologists
|
Revista Española de Enfermedades Digestivas |
| Artículo | 2014 |
Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| Artículo | 2014 |
Síndrome LPAC secundario a deleción del exón 4 del gen ABCB4 en un paciente con hepatitis C
|
Revista Española de Enfermedades Digestivas |
| Editorial | 2014 |
Stanozolol-induced bland cholestasis
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Letter | 2014 |
Tetany and convulsions: Onset symptoms in crohn’s disease
|
Revista Española de Enfermedades Digestivas |
| Artículo | 2013 |
Esteatohepatitis alcohólica y no alcohólica: ¿quiénes son los pacientes y qué podemos hacer por ellos?
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Revisión | 2013 |
Hepatobiliary manifestations in inflammatory bowel disease: The gut, the drugs and the liver
|
WORLD JOURNAL OF GASTROENTEROLOGY |
| Resumen congreso | 2013 |
I148M PNPLA3 variant promotes steatosis according to viral and IL28B genotype but does not affect sustained viral response in patients with hepatitis C
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2013 |
Impacto de la realización de sesiones formativas en la detección de la hepatitis b y c en atención primaria (ver tabla)
|
Revista Andaluza de Patología Digestiva |
| Artículo | 2013 |
Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| Ponencia | 2013 |
KLF12 polymorphism improves ITPA predictability of anemia in hepatitis C treated with peginterferon plus ribavirin
|
HEPATOLOGY |
| Resumen congreso | 2013 |
KLF12 polymorphism rs9543524 predicts anemia in patients with chronic hepatitis C treated with peginterferon and ribavirin
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2013 |
Las variantes de pnpla3 promueven la esteatosis en función del genotipo viral y la ilb28 sin afectar a la respuesta viral sostenida en pacientes con hepatitis C
|
Revista Andaluza de Patología Digestiva |
| Artículo | 2013 |
Meta-analysis: pegylated interferon α-2a achieves higher early virological responses than α-2b in chronic hepatitis C
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| Ponencia | 2013 |
Metformin reduces plasmatic ammonia in portacaval shunted rats
|
HEPATOLOGY |
| Artículo | 2013 |
Metformina reduce los niveles de amonio plástico en ratas con derivación portocava
|
Revista Andaluza de Patología Digestiva |
| Letter | 2013 |
Mielotoxicidad por la interacción entre azatioprina y alopurinol en paciente con enfermedad de Crohn
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Resumen congreso | 2013 |
Non-alcoholic steatohepatitis increases the production of antibodies against oxidized LDL, atherosclerosis and cardiovascular risk
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2013 |
Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables
|
ANNALS OF HEPATOLOGY |
| Artículo | 2013 |
Role of diabetes mellitus on hepatic encephalopathy
|
METABOLIC BRAIN DISEASE |
| Resumen congreso | 2013 |
Validation study of the impact of SNPs from GWAS associated with fibrosis progression in chronic hepatitis C (HCV)
|
HEPATOLOGY |
| Artículo | 2012 |
5. Recidiva tras el cambio de la doble terapia a la monoterapia en la enfermedad de Crohn
|
Revista Andaluza de Patología Digestiva |
| Artículo | 2012 |
Influencia de la enfermedad hepática por hígado graso no alcohólico sobre la enfermedad cardiovascular: Metaanálisis
|
Revista Andaluza de Patología Digestiva |
| Artículo | 2012 |
Influencia de la enfermedad por hígado graso no alcohólico en la enfermedad cardiovascular
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Artículo | 2012 |
Interacción entre los genotipos virales y del hospedador influenciados por la infección del virus de la hepatitis C
|
Revista Andaluza de Patología Digestiva |
| Artículo | 2012 |
Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy
|
PLOS ONE |
| Ponencia | 2012 |
Non-alcoholic fatty liver disease (NAFLD) influences on cardiovascular disease: Meta-analysis
|
HEPATOLOGY |
| Artículo | 2012 |
Pancreatitis aguda e infección por Salmonella Enteritidis
|
Revista Andaluza de Patología Digestiva |
| Ponencia | 2012 |
PNPLA3 and DISC1 are associated with steatosis in patients with chronic hepatitis C
|
HEPATOLOGY |
| Letter | 2012 |
Unsedated colonoscopy: an option for some but not for all
|
GASTROINTESTINAL ENDOSCOPY |
